发明名称 |
Redirection of cellular immunity by protein-tyrosine kinase chimeras |
摘要 |
cell which expresses a membrane-bound proteinaceous chimeric receptor is claimed comprising: (a).an intracellular portion of a protein-tyrosine kinase which is capable of signaling the therapeutic cell to destroy a receptor-bound target cell or a receptor-bound target infective agent and (b).an extracellular portion which is capable of specifically recognizing and binding the target cell or target infective agent whereby each of the therapeutic cells is capable of specifically recognizing and destroying the target cell or target infective agent. Also claimed is the DNA encoding the chimeric receptors. Divisional filed as 501340 |
申请公布号 |
NZ302090(A) |
申请公布日期 |
2000.01.28 |
申请号 |
NZ19960302090 |
申请日期 |
1996.01.24 |
申请人 |
THE GENERAL HOSPITAL CORP |
发明人 |
SEED, BRIAN;ROMEO, CHARLES;KOLANUS, WALDEMAR |
分类号 |
C12N15/09;A61K35/12;A61K35/14;A61K38/00;A61K48/00;C07K14/705;C07K14/725;C07K14/73;C07K14/735;C07K19/00;C12N5/08;C12N5/10;C12N9/12;C12N15/62;C12N15/863;(IPC1-7):A61K48/00;C12N15/79;C12N15/00;C12N15/63;C12N5/00 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|